DANIEL LYNCH - 10 Feb 2025 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
Director
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
Issuer symbol
SWTX
Transactions as of
10 Feb 2025
Net transactions value
-$9,530,351
Form type
4
Filing time
12 Feb 2025, 19:59:41 UTC
Previous filing
17 May 2024
Next filing
19 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Sale $3,713,553 -69,766 -23% $53.23 236,178 10 Feb 2025 Direct F1, F2
transaction SWTX Common Stock Sale $2,175,047 -39,634 -17% $54.88 196,544 10 Feb 2025 Direct F1, F3
transaction SWTX Common Stock Sale $3,641,751 -65,600 -33% $55.51 130,944 10 Feb 2025 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on May 3, 2024.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.28 to $55.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.40 to $55.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.